In situ immune response in human dermatophytosis: possible role of Langerhans cells (CD1a+) as a risk factor for dermatophyte infection

Carregando...
Imagem de Miniatura
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
INST MEDICINA TROPICAL SAO PAULO
Citação
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, v.61, article ID UNSP e56, 6p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Dermatophytosis is a cutaneous mycosis caused by a plethora of keratinophilic fungi, but Trichophyton rubrum is the most common etiological agent. Despite its high prevalence worldwide, little is known about the host defense mechanisms in this infection, particularly the in situ immune response. Using an immunohistochemistry approach, we investigated the density of CD1a+, factor XIIIa+ and CD68+ cells in the skin of dermatophytosis patients. Langerhans cells (CD1a+ cells) were significantly decreased in the epidermis of patients, both in affected and unaffected areas. In the dermis, however, no differences in the density of macrophages (CD68+ cells) and dermal dendrocytes (factor XIIIa+ cells) were observed. These results suggest that the decreased number of Langerhans cells may be a risk factor for development of dermatophytosis.
Palavras-chave
Dermatophytosis, Innate immune response, Langerhans cells, Macrophages, CD68+, Factor XIIIa, CD1a+, Trichophyton rubrum
Referências
  1. Asahina A, 2006, J DERMATOL SCI, V44, P1, DOI 10.1016/j.jdermsci.2006.07.002
  2. Bhatia VK, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-134
  3. Blanco JL, 2008, VET IMMUNOL IMMUNOP, V125, P47, DOI 10.1016/j.vetimm.2008.04.020
  4. BRAATHEN LR, 1983, BRIT J DERMATOL, V109, P295, DOI 10.1111/j.1365-2133.1983.tb03544.x
  5. BRASCH J, 1991, MYCOSES, V34, P365
  6. Burstein VL, 2018, J INVEST DERMATOL, V138, P1744, DOI 10.1016/j.jid.2018.02.042
  7. Chai LYA, 2009, MED MYCOL, V47, P227, DOI 10.1080/13693780802209082
  8. Criado PR, 2011, AN BRAS DERMATOL, V86, P726, DOI 10.1590/S0365-05962011000400015
  9. de Medeiros AKA, 2016, J CLIN IMMUNOL, V36, P204, DOI 10.1007/s10875-016-0255-8
  10. de Sousa MDT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00801
  11. Drewniak A, 2013, BLOOD, V121, P2385, DOI 10.1182/blood-2012-08-450551
  12. da Silva WLF, 2016, MED MYCOL, V54, P370, DOI 10.1093/mmy/myv112
  13. Grumach AS, 2015, J CLIN IMMUNOL, V35, P486, DOI 10.1007/s10875-015-0170-4
  14. Heinen MP, 2019, J INVEST DERMATOL, V139, P626, DOI 10.1016/j.jid.2018.07.040
  15. Heinen MP, 2017, MYCOPATHOLOGIA, V182, P251, DOI 10.1007/s11046-016-0093-5
  16. HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661
  17. Jabbour MN, 2015, J EUR ACAD DERMATOL, V29, P1170, DOI 10.1111/jdv.12781
  18. JONES HE, 1973, ARCH DERMATOL, V108, P61, DOI 10.1001/archderm.108.1.61
  19. Kang KF, 1996, J IMMUNOL, V156, P1402
  20. Kaviarasan P K, 2002, Indian J Dermatol Venereol Leprol, V68, P213
  21. LAMBKIN I, 1994, MYCOSES, V37, P85
  22. Lanternier F, 2015, J ALLERGY CLIN IMMUN, V135, P1558, DOI 10.1016/j.jaci.2014.12.1930
  23. Lanternier F, 2013, NEW ENGL J MED, V369, P1704, DOI 10.1056/NEJMoa1208487
  24. Leibovici V, 1995, CLIN EXP DERMATOL, V20, P390, DOI 10.1111/j.1365-2230.1995.tb01355.x
  25. Marconi VC, 2010, MED MYCOL, V48, P518, DOI 10.3109/13693780903213512
  26. Martinez-Herrera EO, 2015, AN BRAS DERMATOL, V90, P334, DOI 10.1590/abd1806-4841.20153521
  27. Martinez-Rossi NM, 2017, MYCOPATHOLOGIA, V182, P215, DOI 10.1007/s11046-016-0057-9
  28. Matejuk A, 2018, ARCH IMMUNOL THER EX, V66, P45, DOI 10.1007/s00005-017-0477-3
  29. Pagliari C, 2002, MED MYCOL, V40, P407, DOI 10.1080/714031129
  30. PAKULA AS, 1993, J AM ACAD DERMATOL, V29, P340, DOI 10.1016/0190-9622(93)70191-U
  31. Park YW, 2014, ANN DERMATOL, V26, P286, DOI 10.5021/ad.2014.26.2.286
  32. Seebacher C, 2008, MYCOPATHOLOGIA, V166, P335, DOI 10.1007/s11046-008-9100-9
  33. Sieling PA, 1999, J IMMUNOL, V162, P1851
  34. Sotto MN, 2010, AM J DERMATOPATH, V32, P15, DOI 10.1097/DAD.0b013e3181ab4695
  35. Teklebirhan G, 2015, INT J MICROBIOL, V2015
  36. WEITZMAN I, 1995, CLIN MICROBIOL REV, V8, P240, DOI 10.1128/CMR.8.2.240